Cite
HARVARD Citation
Flinn, I. et al. (2016). A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). European journal of cancer. pp. 11-17. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Flinn, I. et al. (2016). A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). European journal of cancer. pp. 11-17. [Online].